PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-340

  1. 1,048 Posts.
    lightbulb Created with Sketch. 531
    If you are right about the raising being covered 4x it only highlights what a poor capital management decision the board made.
    1. PAR don't need the money until 2021
    2. Markets have seen the light at the end of the COVID-19 tunnel
    3. A much better outcome for retail investors would have been
    a) get it from us
    b) allow BP customers to come in to pick up any slack
    c) set a date of Sept 30 for the raising on those terms

    Email --
    If you want retail opportunity at $1.30 let Rennie know how disappointed you are via the investor relations guy. Tell them if they can, pull it, get it from us with BP as a backstop.
    [email protected]

    If you let things happen to you they keep on happening.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.